Science Explorer Interactive view Map
Company · Tartu · Estonia

Icosagen (Estonia)

icosagen.comROR OpenAlex
Research works
35
▼ 29% vs 2013–17
Citations
648
18.7 per fractional work
Top-10% rate
10.4%
record average 16.5%
Open access
60%
world 28%

Not ranked overall: Icosagen (Estonia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.73× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 8.29× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 8.88× its world share, 1 worksImmunology and Micro…Neuroscience: 0.31× its world share, 0 worksNeuroscienceComputer Science: 0.05× its world share, 0 worksComputer ScienceEngineering: 0.04× its world share, 0 worksEngineeringEnvironmental Science: 0.65× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.17× its world share, 0 worksMaterials ScienceHealth Professions: 0.27× its world share, 0 worksHealth ProfessionsMedicine: 1.88× its world share, 3 worksMedicineSocial Sciences: 0.09× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.9×. Every wedge is a field page.

Which keywords describe research at Icosagen (Estonia)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Gene Therapy, Ion Channels, Immune Response, Glycosylation, Vaccine, Immunotherapy and Global Burden.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology5▲ 3.3×21 topics
  2. Gene Therapy3▲ 31×4 topics
  3. Ion Channels2▲ 31×2 topics
  4. Glycosylation2▲ 29×3 topics
  5. Immune Response2▲ 10×8 topics
  6. Vaccine2▲ 14×6 topics
  7. Inflammation2▲ 2.2×10 topics
  8. Immunotherapy2▲ 7.7×6 topics
  9. Global Burden2▲ 8.6×3 topics
  10. Human Papillomavirus2▲ 36×3 topics
  11. Cell Signaling2▲ 13×2 topics
  12. Membrane Proteins2▲ 24×2 topics
  13. Neuronal Function2▲ 38×2 topics
  14. Cell Culture1▲ 36×2 topics
  15. Monoclonal Antibodies1▲ 29×3 topics
  16. Therapeutic Antibodies1▲ 31×2 topics
  17. AAV1▲ 56×1 topic
  18. Calcium Channels1▲ 52×1 topic
  19. Cancer1▲ 2.7×10 topics
  20. Cancer Incidence1▲ 25×2 topics
  21. Pathogenesis1▲ 6.7×5 topics
  22. Viral Vectors1▲ 56×1 topic
  23. Voltage-Gated Channels1▲ 52×1 topic
  24. Viral Oncoproteins1▲ 47×2 topics
  25. Cervical Cancer1▲ 32×2 topics
  26. Cytology Screening1▲ 60×1 topic
  27. Gene Silencing1▲ 27×2 topics
  28. Genetic Testing1▲ 20×2 topics
  29. HPV Vaccination1▲ 60×1 topic
  30. Mammalian Cells1▲ 78×1 topic
  31. Neurological Disorders1▲ 4.6×2 topics
  32. Recombinant Protein1▲ 78×1 topic
  33. Tumor Regression1▲ 36×2 topics
  34. Viral Transmission1▲ 32×4 topics
  35. Arrhythmias1▲ 22×1 topic
  36. Cancer Therapy1▲ 4.7×6 topics
  37. Long-QT Syndrome1▲ 39×1 topic
  38. Neurotransmission1▲ 22×1 topic
  39. Sexually Transmitted Infections1▲ 53×2 topics
  40. Synaptic Plasticity1▲ 9.3×1 topic

Which research topics does Icosagen (Estonia) publish most on?

By volume in 2022–2025: Atherosclerosis and Cardiovascular Diseases, CAR-T cell therapy research, SARS-CoV-2 and COVID-19 Research and Cancer-related Molecular Pathways.

Atherosclerosis and Card…0Atherosclerosis and Cardiovascular Diseases: 0 fractional worksCAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksSARS-CoV-2 and COVID-19 Research: 0 fractional worksCancer-related Molecular Pathways: 0 fractional worksViral Infectious Diseases and Gene Expression in Insects: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional worksVirus-based gene therapy…0Virus-based gene therapy research: 0 fractional worksLiver Disease Diagnosis and Treatment: 0 fractional worksDiabetes and associated disorders: 0 fractional works
ImmunologyOncologyInfectious DiseasesMolecular Biology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Atherosclerosis and Cardiovascular Diseases Immunology 0 works
  2. 2 CAR-T cell therapy research Oncology 0 works
  3. 3 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  4. 4 Cancer-related Molecular Pathways Oncology 0 works
  5. 5 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  8. 8 Virus-based gene therapy research Genetics 0 works
  9. 9 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  10. 10 Diabetes and associated disorders Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available60.1%not open39.9%

World: 28% of research is openly available.

with international co-authors44.8%domestic only55.2%

World: 19% is written across borders.

How has Icosagen (Estonia)'s research output changed?

Output in 2018–2022 was 29% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tartu

All research institutions in Tartu

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.